Update on InnomarClinics
InnomarClinics remain open to our patients amidst coronavirus (COVID-19) concerns.
Unique challenges for commercializing in Canada
The Pharma Letter |
Commercializing a specialty pharmaceutical product in Canada is complex. It requires proactive planning and unique considerations. With Innomar Strategies being the first full service distributor and support services company in the specialty marketplace in Canada to offer a comprehensive portfolio of commercialization services, Guy Payette, President, Innomar Strategies was asked by PharmaLetter for his insights.